Comments

Corvus Pharma Stock Price, Quotes and Forecasts

Q: What sector and industry does Corvus Pharma (CRVS) operate in?

Corvus Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

CRVSNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$4.25

0.000.00%

Pre-Market: 5:01 PM EDT

Q4 2024 earnings announcement after the market close today

Conference call scheduled today at 16:30 PM Click to view the webcast

Corvus Pharma (CRVS) Forecast

News Earnings Corvus Pharma (CRVS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Corvus Pharma Stock Price, Quotes and Forecasts | NASDAQ:CRVS | Benzinga

Explore Corvus Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CRVS.

Open	-
Close	-
Volume / Avg.	0 / 582.50K
Day Range	- - -
52 Wk Range	1.30 - 10.00
Market Cap	$273.09M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	10.26%
Days to Cover	7.28

Recent News

This Kopin Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Avi Kapoor

Why Is Corvus Pharmaceuticals Stock Trading Lower On Wednesday?

Corvus Pharmaceuticals shares interim Phase 1 trial data showing promising results for soquelitinib in treating moderate to severe atopic dermatitis.

Vandana Singh

Crude Oil Gains Over 1%, General Mills Shares Fall

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 582.50K
Day Range	- - -
52 Wk Range	1.30 - 10.00
Market Cap	$273.09M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	10.26%
Days to Cover	7.28

About Corvus Pharmaceuticals Inc

Sector

Health Care

Industry

Biotechnology

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and ant...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Corvus Pharma (CRVS) stock?

You can purchase shares of Corvus Pharma (NASDAQ:CRVS) through any online brokerage.

View our list of the best stock brokerages

Who are Corvus Pharma (CRVS) competitors?

Other companies in Corvus Pharma’s space includes: Monopar Therapeutics (NASDAQ:MNPR), aTyr Pharma (NASDAQ:ATYR), Olema Pharmaceuticals (NASDAQ:OLMA), Ironwood Pharmaceuticals (NASDAQ:IRWD) and Design Therapeutics (NASDAQ:DSGN).

What is the forecast, or price target, for Corvus Pharma (CRVS) stock?

Corvus Pharma has a consensus price target of $10.60.

What is the current price for Corvus Pharma (CRVS)?

The stock price for Corvus Pharma (NASDAQ: CRVS) is $4.25 last updated March 24, 2025 at 5:01 PM EDT.

Does Corvus Pharma (CRVS) pay a dividend?

There are no upcoming dividends for Corvus Pharma.

When is Corvus Pharma (NASDAQ:CRVS) reporting earnings?

Corvus Pharma’s Q1 earnings are confirmed for Monday, May 5, 2025.

Is Corvus Pharma (CRVS) going to split?

There is no upcoming split for Corvus Pharma.

What sector and industry does Corvus Pharma (CRVS) operate in?

Corvus Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.